The news: A problematic Maryland vaccine plant making Johnson & Johnson’s COVID-19 vaccine still doesn’t have regulatory approvals, even after the Food and Drug Administration declared several batches from the plant were safe.
FDA on June 11 cleared two batches of the Johnson & Johnson vaccine produced at the plant, and cleared a third batch this week.
The FDA has cleared a total of 25 million Johnson & Johnson doses from the Maryland plant, according to The Wall Street Journal. Additional...
This is an excerpt from Medically Necessary, a health care supply chain newsletter. Subscribe here.
The report: The White House released a report last week that examined vulnerabilities in the pharmaceutical supply chain and offered recommendations to fix those problems.
The report largely focused on the ongoing problem of drug shortages, especially for cheap generic medicines. The number of new shortages of drugs peaked at about 250 in 2011. That number has fallen sharply since then, but ongoing...
https://www.freightwaves.com/news/white-house-charts-a-course-for-drug-supply-chain